Aimmune Therapeutics
- Pharmaceutical Preparations
- Brisbane, California
Compensation history
Top executives at Aimmune Therapeutics received an average of $2M per person in annual compensation from 2014 to 2019.
Average pay of disclosed executives at Aimmune Therapeutics
By year
Executives
We found ten executives who work or worked at Aimmune Therapeutics.
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
Andrew Oxtoby
Aimmune Therapeutics
Chief Commercial Officer
Douglas Sheehy
Aimmune Therapeutics
General Counsel
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
Susan Barrowcliffe
Aimmune Therapeutics
General Manager, Europe
Jeffrey Knapp
Aimmune Therapeutics
Chief Operating Officer
News
About Aimmune Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address8000 Marina Boulevard, Suite 300, Brisbane, California 94005-1884
- Phone(650) 614-5220
- Fiscal year endDecember 31
- Former names
- Allergen Research CorpUntil March 23, 2015
Source: SEC filings on April 9, 2020, April 10, 2019, April 11, 2018, and April 12, 2016.